Terug
Ook genoteerd als
DGWPF
OTC
Dagbereik
€ 109,51
€ 109,51
52-Weeksbereik
€ 58,15
€ 111,00
Volume
100
50D / 200D Gem.
€ 99,68
/
€ 81,59
Vorige Slotkoers
€ 104,99
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 16,5 | 0,3 |
| P/B | 1,3 | 2,9 |
| ROE % | 8,5 | 3,7 |
| Net Margin % | 3,7 | 3,8 |
| Rev Growth 5Y % | -0,3 | 10,0 |
| D/E | 0,3 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 10,78
€ 10,45 – € 11,47
|
3,9 B | 1 |
| FY2028 |
€ 10,18
€ 9,87 – € 10,83
|
3,8 B | 1 |
| FY2027 |
€ 8,64
€ 8,37 – € 9,18
|
3,7 B | 1 |
Belangrijkste Punten
Revenue declined -0,26% annually over 5 years
Debt/Equity of 0,26 — conservative balance sheet
Generating 103,52M in free cash flow
PEG of 0,55 suggests growth is underpriced
Cash machine — converts 83,21% of earnings into free cash flow
Capital efficient — spends only 1,89% of revenue on capex
Groei
Revenue Growth (5Y)
-0,26%
Revenue (1Y)-0,08%
Earnings (1Y)12,65%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
8,46%
ROIC6,99%
Net Margin3,69%
Op. Margin5,34%
Veiligheid
Debt / Equity
0,26
Current Ratio1,93
Interest Coverage6,65
Waardering
P/E Ratio
16,51
P/B Ratio1,34
EV/EBITDA12,37
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0,08% | Revenue Growth (3Y) | 5,21% |
| Earnings Growth (1Y) | 12,65% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -0,26% | Earnings Growth (5Y) | -16,02% |
| Profitability | |||
| Revenue (TTM) | 3,37B | Net Income (TTM) | 124,41M |
| ROE | 8,46% | ROA | 4,02% |
| Gross Margin | 44,87% | Operating Margin | 5,34% |
| Net Margin | 3,69% | Free Cash Flow (TTM) | 103,52M |
| ROIC | 6,99% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,26 | Current Ratio | 1,93 |
| Interest Coverage | 6,65 | Dividend Yield | 0,04% |
| Valuation | |||
| P/E Ratio | 16,51 | P/B Ratio | 1,34 |
| P/S Ratio | 0,61 | PEG Ratio | 0,55 |
| EV/EBITDA | 12,37 | Dividend Yield | 0,04% |
| Market Cap | 2,05B | Enterprise Value | 2,23B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 3,37B | 3,37B | 3,05B | 3,33B | 3,41B |
| Net Income | 124,41M | 110,43M | -64,56M | 154,23M | 250,16M |
| EPS (Diluted) | 6,61 | 5,89 | -3,44 | 7,16 | 10,22 |
| Gross Profit | 1,51B | 1,46B | 1,24B | 1,54B | 1,61B |
| Operating Income | 180,01M | 184,13M | -79,76M | 277,68M | 411,53M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 3,09B | 3,09B | 3,11B | 3,18B | 3,31B |
| Total Liabilities | 1,56B | 1,69B | 1,79B | 1,92B | 2,27B |
| Shareholders' Equity | 1,54B | 1,41B | 1,32B | 1,26B | 1,03B |
| Total Debt | 395,58M | 471,38M | 361,95M | 348,01M | 370,75M |
| Cash & Equivalents | 223,47M | 260,00M | 302,47M | 439,44M | 492,23M |
| Current Assets | 1,88B | 1,87B | 1,90B | 1,99B | 2,15B |
| Current Liabilities | 978,48M | 1,02B | 1,22B | 934,91M | 1,15B |